Transcontinental Wound Registry



The Academy of Wound Technology is to develop a Transcontinental Wound Registry for the 2012 WUWHS Congress. Governments and private payers throughout the world are requiring increased levels of effectiveness data as the basis for coverage and payment policies for a wide range of medical products and services. Although the Randomized Clinical Trial (RCT) is still the preferred level of evidence, payers are beginning to recognize the challenges of conducting RCTs in compromised sub-populations of patients who are routinely excluded from these trials because of complicating conditions which are difficult to match in control groups.

This challenge is particularly relevant to wound healing and tissue repair. Conditions such as diabetes, immobility, nutritional compromise, immune system suppression and chemotherapy, among others, have significant impact on wound healing must be managed in a comprehensive wound care plan. In addition, the relative significance of each co-morbid condition could impact the goal of healing, the rate of healing, and, therefore both the time to heal and the level of resources required for healing.

Also, given that healing occurs in phases and most products are not indicated for all phases, it is not uncommon for compromised wound care patients to require multiple interventions, sometimes administered concurrently. In addition, the future landscape of wound care will include systemic therapy, cell based treatments, and gene therapy all which will require even more complex regulatory pathways and levels of evidence. Simply stated, what works for one patient may not work for another, but the RCT may not be the best tool for determining which patients needs which protocols for optimal care.

How then, can the wound care community generate adequate effectiveness for all patients, regardless of overall health status or site of service? The answer may lie in a wound care registry. Registries exclude no patients and can be constructed to include data from all care settings. With adequate data collection, patients can be subdivided and stratified to better assess comparability on an “apples to apples” basis. For these reasons, the World Union of Wound Healing Societies is proposing the development of a TransContinental Wound Registry.

The overall goal of the project is: Identification of Factors Which Optimize Clinical and Economic Outcomes in Wound Healing and Tissue Repair. The project will include three phases:

  • PHASE I – Profile current global wound healing practices (proof of concept by 2nd September 2012 Yokohama, Japan)
  • PHASE II – Identify predictive factors which lead to optimal wound healing (2014)
  • PHASE III – Evaluate the economic impact of optimal

The project is designed to be funded in part by the medical products industry (proof of concept) and in part by governments interested in wound healing research. All interested parties such as local decision makers, regulation authorities, wound experts and industry are invited to attend the important launch meeting on the 9th of September in Seoul, South Korea.

Scientific Committee

Luc Téot
MD, PhD, Hôpital Lapeyronie, Montpellier, France
Sylvie Meaume
MD, Assistance Publique Hôpitaux de Paris, Hôpital Rothschild, Paris, France